Prescription medicines: applications under evaluation

22 September 2021 - The TGA has updated the list of applications for new medicines or new uses for existing ...

Read more →

TGA approves Leqvio

22 September 2021 - Inclisiran is a cholesterol lowering double-stranded small interfering ribonucleic acid. ...

Read more →

Australia eyes Pfizer’s Covid-19 vaccines for kids aged 5 to 11

21 September 2021 - Australian health officials have confirmed if approved the vaccine would be made widely available to children ...

Read more →

ATAGI update following weekly COVID-19 meeting – 15 September 2021

16 September 2021 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 15 ...

Read more →

COVID-19 vaccine weekly safety report (16 September 2021)

16 September 2021 - To 12 September 2021, approximately 22.8 million vaccine doses have been given in Australia – 14 million ...

Read more →

Final report on the Australian Government response to the recommendations of the Senate Community Affairs References Committee Report

15 September 2021 - The Government acknowledges the efforts and actions detailed in this progress report to implement the Senate ...

Read more →

Medicines Australia and AusBiotech say COVID-19 vaccine patent waiver will not speed up global vaccination

15 September 2021 - Medicines Australia and AusBiotech, the peak bodies representing the Australian innovative pharmaceutical and biotechnology sectors, urge ...

Read more →

Trodelvy approved by the TGA

14 September 2021 - Sacituzumab govitecan is a new treatment option for adult patients with unresectable locally advanced or metastatic triple negative ...

Read more →

New therapy to treat advanced small cell lung cancer approved for Australian patients

14 September 2021 - Zepzelca approval granted under a provisional regulatory pathway. ...

Read more →

Access Consortium: alignment with ICMRA consensus on immunobridging for authorising new COVID-19 vaccines

14 September 2021 - Placebo controlled disease outcome trial data are the gold standard for authorising vaccines. However, for COVID-19 ...

Read more →

Joint statement of support for an Australian Patent Box

13 September 2021 - Australia’s health innovators support the introduction of a Patent Box, and we welcome this initiative by the ...

Read more →

Trodelvy approved following heroic efforts of breast cancer sufferer Alison Day

12 September 2021 - A dying woman’s selfless campaign will give Australian women battling a rare aggressive form of breast cancer ...

Read more →

COVID-19 vaccine weekly safety report (9 September 2021)

9 September 2021 - To 5 September 2021, approximately 21 million vaccine doses have been given in Australia – 13.1 million ...

Read more →

Joint statement: supply allocations of intravenous tocilizumab (Actemra) during serious shortage

8 September 2021 - Roche, the sponsor of tocilizumab (Actemra), notified the TGA of shortages of multiple presentations of tocilizumab products ...

Read more →

TGA approves new cancer medicine

7 September 2021 - Luspatercept (Reblozyl) is used to treat patients with certain transfusion-dependent anaemias. ...

Read more →